0000000000519409

AUTHOR

Jason Clark

showing 3 related works from this author

Comparison of Delivery Methods in Phage Therapy against Flavobacterium columnare Infections in Rainbow Trout

2021

Viruses of bacteria, bacteriophages, specifically infect their bacterial hosts with minimal effects on the surrounding microbiota. They have the potential to be used in the prevention and treatment of bacterial infections, including in the field of food production. In aquaculture settings, disease-causing bacteria are often transmitted through the water body, providing several applications for phage-based targeting of pathogens, in the rearing environment, and in the fish. We tested delivery of phages by different methods (via baths, in phage-coated material, and via oral delivery in feed) to prevent and treat Flavobacterium columnare infections in rainbow trout fry using three phages (FCOV…

Microbiology (medical)Microbiological culturebakteeritauditphage therapyPhage therapymedicine.medical_treatmentVirulenceRM1-950BiologyBiochemistryMicrobiologyArticlebakteriofagitMicrobiologybakteeritBacteriophage03 medical and health sciencesFlavobacterium columnareAquaculturebacteriophagehoitomenetelmätmedicinePharmacology (medical)General Pharmacology Toxicology and Pharmaceuticsvesiviljely (kalatalous)030304 developmental biology0303 health sciencestreatment030306 microbiologybusiness.industrylohikalatbacterial infectionbiology.organism_classification<i>Flavobacterium columnare</i>rainbow trout3. Good healthfagiterapiavirulenceInfectious Diseasesphage deliveryaquaculturecolumnaris diseaseFlavobacterium columnareRainbow troutTherapeutics. PharmacologybusinessBacteriaAntibiotics
researchProduct

A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in p…

2011

Abstract Purpose: Insulin-like growth factor-1 receptor (IGF-1R) mediates cellular processes in cancer and has been proposed as a therapeutic target. Dalotuzumab (MK-0646) is a humanized IgG1 monoclonal antibody that binds to IGF-1R preventing receptor activation. This study was designed to evaluate the safety and tolerability of dalotuzumab, determine the pharmacokinetic (PK) and pharmacodynamic (PD) profiles, and identify a recommended phase II dose. Experimental Design: Patients with tumors expressing IGF-1R protein were allocated to dose-escalating cohorts of three or more patients each and received intravenous dalotuzumab weekly, every 2 or 3 weeks. Plasma was collected for PK analysis…

AdultMaleCancer ResearchMaximum Tolerated Dosemedicine.medical_treatmentAntineoplastic AgentsPharmacologyAntibodies Monoclonal HumanizedDrug Administration ScheduleReceptor IGF Type 1Insulin-like growth factorPharmacokineticsNeoplasmsmedicineHumansAgedAged 80 and overDose-Response Relationship DrugDalotuzumabbusiness.industryCancerAntibodies MonoclonalMiddle Agedmedicine.diseaseOncologyTolerabilityPharmacodynamicsMonoclonalToxicityFemalebusinessClinical cancer research : an official journal of the American Association for Cancer Research
researchProduct

Comparison of Delivery Methods in Phage Therapy against Flavobacterium columnare Infections in Rainbow Trout

2021

This dataset consists of three phage therapy experiments to prevent Flavobacterium columnare infections in rainbow trout. Experiments I and II were done in stagnant water, and Experiment III in a flow-through system. See the documentation file attached with the dataset for full description of the methods (also found in the original article).

bakteeritauditbacteriophagesbacterial diseaseskirjolohirainbow troutbakteriofagit
researchProduct